The application of rituximab during the conditioning regimen prevents Epstein – Barr virus infection following rATG-based haploidentical hematopoietic stem cell transplantation in the era of letermovir for cytomegalovirus prophylaxis
BackgroundIn the era of letermovir for cytomegalovirus (CMV) prophylaxis, several centers reported that the incidence of Epstein-Barr virus (EBV) infection were significantly increased.ObjectiveTo investigate the efficacy and safety of rituximab admini…